John S. Holcenberg

5.1k total citations · 1 hit paper
98 papers, 3.8k citations indexed

About

John S. Holcenberg is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John S. Holcenberg has authored 98 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Public Health, Environmental and Occupational Health, 37 papers in Molecular Biology and 25 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John S. Holcenberg's work include Acute Lymphoblastic Leukemia research (42 papers), Childhood Cancer Survivors' Quality of Life (20 papers) and Biochemical and Molecular Research (16 papers). John S. Holcenberg is often cited by papers focused on Acute Lymphoblastic Leukemia research (42 papers), Childhood Cancer Survivors' Quality of Life (20 papers) and Biochemical and Molecular Research (16 papers). John S. Holcenberg collaborates with scholars based in United States, Canada and Malaysia. John S. Holcenberg's co-authors include William C. Dolowy, Nita L. Seibel, Peter G. Pappas, Cindy L. Schwartz, David Bodensteiner, John Hiemenz, Stephen Dummer, Richard N. Greenberg, Mindy G. Schuster and Robert W. Finberg and has published in prestigious journals such as Nature, New England Journal of Medicine and Nucleic Acids Research.

In The Last Decade

John S. Holcenberg

95 papers receiving 3.6k citations

Hit Papers

Liposomal Amphotericin B for Empirical Therapy in Patient... 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
    1999 884 citations Thomas J. Walsh, Robert W. Finberg et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Holcenberg United States 29 1.2k 1.1k 895 818 736 98 3.8k
F Zintl Germany 37 1.2k 1.1× 1.2k 1.0× 784 0.9× 259 0.3× 345 0.5× 161 4.1k
Joseph H. Burchenal United States 34 1.1k 1.0× 1.3k 1.1× 527 0.6× 260 0.3× 336 0.5× 147 4.3k
Francis M. Sirotnak United States 42 815 0.7× 2.8k 2.5× 340 0.4× 317 0.4× 309 0.4× 170 5.6k
H. Anne Simmonds United Kingdom 37 360 0.3× 3.1k 2.8× 811 0.9× 758 0.9× 1.5k 2.1× 257 5.3k
Robert L. Capizzi United States 37 976 0.8× 1.3k 1.2× 333 0.4× 212 0.3× 265 0.4× 134 4.0k
Gareth J. Veal United Kingdom 32 348 0.3× 1.3k 1.2× 615 0.7× 391 0.5× 310 0.4× 136 3.7k
Irwin H. Krakoff United States 32 483 0.4× 1.5k 1.4× 362 0.4× 158 0.2× 366 0.5× 124 4.5k
D H Ho United States 27 424 0.4× 887 0.8× 205 0.2× 317 0.4× 308 0.4× 100 2.5k
Nanno H. Mulder Netherlands 43 442 0.4× 2.2k 2.0× 514 0.6× 264 0.3× 527 0.7× 229 6.9k
Suradej Hongeng Thailand 35 752 0.7× 1.6k 1.4× 706 0.8× 348 0.4× 352 0.5× 318 4.7k

Countries citing papers authored by John S. Holcenberg

Since Specialization
Citations

This map shows the geographic impact of John S. Holcenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Holcenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Holcenberg more than expected).

Fields of papers citing papers by John S. Holcenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Holcenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Holcenberg. The network helps show where John S. Holcenberg may publish in the future.

Co-authorship network of co-authors of John S. Holcenberg

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Holcenberg. A scholar is included among the top collaborators of John S. Holcenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Holcenberg. John S. Holcenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaubiger, Daniel, et al.. (2015). The Relative Tolerance of Children and Adults to Anticancer Drugs. Frontiers of radiation therapy and oncology. 16. 42–49. 1 indexed citations
2.
3.
Holcenberg, John S.. (2005). New Insights on Asparaginase. Journal of Pediatric Hematology/Oncology. 27(5). 246–247. 3 indexed citations
4.
Thomson, Blythe, Julie R. Park, Judy Felgenhauer, et al.. (2004). Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse. Pediatric Blood & Cancer. 43(5). 571–579. 14 indexed citations
5.
Hawkins, Douglas S., Julie R. Park, Blythe Thomson, et al.. (2004). Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-Conjugated L-Asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia. Clinical Cancer Research. 10(16). 5335–5341. 88 indexed citations
6.
Huang, Sheng‐He, et al.. (2003). Amplification of Gene Ends from Gene Libraries by Polymerase Chain Reaction with Single-Sided Specificity. Humana Press eBooks. 15. 357–364. 3 indexed citations
7.
Huang, Sheng-He, et al.. (2003). cDNA Cloning by Inverse Polymerase Chain Reaction. Humana Press eBooks. 15. 349–356.
8.
Ettinger, Alice G., David L. Veenstra, Paul S. Gaynon, et al.. (2002). A Pharmacoeconomic Analysis of Pegaspargase Versus Native Escherichia Coli l-Asparaginase for the Treatment of Children With Standard-Risk, Acute Lymphoblastic Leukemia: The Children's Cancer Group Study (CCG-1962). Journal of Pediatric Hematology/Oncology. 24(3). 175–181. 38 indexed citations
9.
Goldman, Stanton, John S. Holcenberg, Jerry Z. Finklestein, et al.. (2001). A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 97(10). 2998–3003. 301 indexed citations
10.
Walsh, Thomas J., Robert W. Finberg, Carola Arndt, et al.. (1999). Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia. New England Journal of Medicine. 340(10). 764–771. 884 indexed citations breakdown →
11.
12.
Holcenberg, John S., John M. Tomich, Jeannie Chen, et al.. (1990). Inhibition in vitro transcription by specific double-stranded oligodeoxyribonucleotides. Gene. 89(2). 203–209. 10 indexed citations
13.
Fish, Brian L., et al.. (1990). Hepatic function and drug pharmacokinetics after total body irradiation plus bone marrow transplant. International Journal of Radiation Oncology*Biology*Physics. 19(6). 1389–1396. 22 indexed citations
14.
Huang, Sheng‐He, et al.. (1990). A simple method for direct cloning cDNA sequence that flanks a region of known sequence from total RNA by applying the inverse polymerase chain reaction. Nucleic Acids Research. 18(7). 1922–1922. 40 indexed citations
15.
Winick, Naomi, et al.. (1987). Folate and Methotrexate Polyglutamate Tissue Levels in Rhesus Monkeys Following Chronic Low-Dose Methotrexate. PubMed. 4(1). 25–31. 16 indexed citations
16.
Balis, Frank M., John S. Holcenberg, Solomon Zimm, et al.. (1987). The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clinical Pharmacology & Therapeutics. 41(4). 384–387. 62 indexed citations
17.
Ungerleider, Richard S., C B Pratt, John S. Holcenberg, et al.. (1985). Phase I trial of mitoxantrone in children.. PubMed. 69(4). 403–7. 15 indexed citations
18.
Kien, C. Lawrence & John S. Holcenberg. (1981). Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase.. PubMed. 41(6). 2051–5. 8 indexed citations
19.
Holcenberg, John S., Luis Borella, Bruce M. Camitta, & Barbara J. Ring. (1979). Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(8). 3145–51. 14 indexed citations
20.
Holcenberg, John S., et al.. (1973). Treatment of Overdose and Withdrawal of Abused Drugs. Postgraduate Medicine. 54(6). 123–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Zintl Breakdown of academic impact, for papers by Joseph H. Burchenal Breakdown of academic impact, for papers by Francis M. Sirotnak Breakdown of academic impact, for papers by H. Anne Simmonds Breakdown of academic impact, for papers by Robert L. Capizzi Breakdown of academic impact, for papers by Gareth J. Veal Breakdown of academic impact, for papers by Irwin H. Krakoff Breakdown of academic impact, for papers by D H Ho Breakdown of academic impact, for papers by Nanno H. Mulder Breakdown of academic impact, for papers by Suradej Hongeng
Rankless by CCL
2026